Thank you very much, Mr. Chair.
My thanks to our witnesses for joining us today.
Professor Beaudry, I would like to talk about the way in which we can improve the research funding system in Canada. You mentioned companies that have developed rapidly because of their good patents. Which indicators should we use to distinguish good patents from bad ones, or less useful ones, so that the system can be improved?